NumFin

NGL Fine-Chem Limited

符号: NGLFINE.NS

NSE

2163.7

INR

今天的市场价格

  • 37.5429

    市盈率

  • -0.6372

    PEG比率

  • 13.37B

    MRK市值

  • 0.00%

    DIV收益率

NGL Fine-Chem Limited (NGLFINE-NS) 财务报表

Download
年度季度
线性对数
在图表中，您可以看到 的动态默认数字 NGL Fine-Chem Limited (NGLFINE.NS). 的默认数据。公司收入显示 1132.519 M 的平均值，即 0.239 % 增长率。整个期间的平均毛利润为 606.66 M，即 0.314 %. 平均毛利率为 0.496 %. 公司去年的净收入增长率为 -0.589 %，等于 1.140 % % 整个公司历史的平均增长率.,

年度季度
10Y20Y30Y40Y

资产负债表

深入分析 NGL Fine-Chem Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为 ，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.333. 在流动资产领域，NGLFINE.NS 的报告货币为1626.567. 这些资产中的很大一部分，即 575.024 是现金和短期投资。与去年的数据相比，该部分的变化率为0.885%. 公司的长期投资虽然不是其重点，但以报告货币计算的43.869（如果有的话）为43.869。这表明与上一报告期相比，70.770% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 20.731. 这一数字表明，0.824% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 2225.491. 这方面的年同比变化率为 0.095%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为658.714，存货估值为 269.93，商誉估值为 1.53（如有. 无形资产总额（如果有）按 1.73 估值. 应付账款和短期债务分别为 245.86 和 284.06. 债务总额为304.79，债务净额为 226.5. 其他流动负债为 0.01，加上总负债 645.3. 最后，如果存在推荐股票，则其估值为 2204.56.

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

balance-sheet.row.cash-and-short-term-investments

2456.89575305.1338.5
145.5
132.1
110.5
70.5
52.3
39.4
11.4
15.3
7.5
8.1
10.4
10.9

balance-sheet.row.short-term-investments

3537.22496.7298.7317.5
141.5
124.2
95.6
50.4
31.1
20.7
4.1
0
0
0
0
0

balance-sheet.row.net-receivables

1358.65658.7712.4405.9
338.7
349.2
0
374.3
345.1
279.4
257.1
170.3
123.2
0
0
0

balance-sheet.row.inventory

658.32269.9560.1378.5
279
186.1
168.1
118.1
100.2
121.2
85
98.8
57.8
47.9
41.4
37.9

balance-sheet.row.other-current-assets

256.47122.9157.4122.3
45.5
46.5
282.8
1.3
0.7
0.3
1.1
7.8
7.3
141
117.6
85.5

balance-sheet.row.total-current-assets

4730.331626.61734.91245.3
808.6
713.9
561.4
564.1
498.3
440.3
354.6
292.2
195.8
197
169.4
134.3

balance-sheet.row.property-plant-equipment-net

2331.611139947.5759.8
673.5
608.2
594.4
405.7
255.6
182.4
186.4
175.5
149
115.3
74.5
64.6

balance-sheet.row.goodwill

1.531.51.51.5
1.5
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

4.391.733.5
2.4
1.2
1.8
1.7
0
2.8
0
0
0
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

5.913.34.65
3.9
1.2
1.8
1.7
1.6
2.8
2.2
0
0
0
0
0

balance-sheet.row.long-term-investments

-589.8743.925.7-271.1
-7.4
-44.2
17.3
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

751.8943.656.6338.7
57.6
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

-1130.3214.500
0
142.8
118
41
19.5
39.6
15.2
6.3
27.1
16.3
9.8
4.7

balance-sheet.row.total-non-current-assets

1369.221244.21034.4832.4
727.6
708
731.5
448.4
276.8
224.9
203.9
181.8
176.1
131.6
84.3
69.3

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

6099.562870.82769.32077.7
1536.2
1421.9
1292.9
1012.5
775.1
665.2
558.5
474
371.9
328.5
253.6
203.6

balance-sheet.row.account-payables

691.27245.9371.6295.3
208.3
161.2
235.3
144.6
136.5
171.3
116.2
116.2
80.1
0
0
0

balance-sheet.row.short-term-debt

544.5284.1265.7103.2
199.1
191.6
143.1
109.4
124.5
116.2
114.6
87.5
49.8
0
0
0

balance-sheet.row.tax-payables

9.419.40.310.3
0
8.3
0.5
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

32.3920.734.461.3
83.2
80.1
123.6
94.6
3.1
15.7
33.6
31.5
37.7
63.1
50.5
41.4

Deferred Revenue Non Current

59.912725.524.6
21.1
14
14.9
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

30.02---
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

3.35000
222.1
20.7
25.6
42.5
24.7
22.1
23
16.4
18.7
99.9
63.1
47.8

balance-sheet.row.total-non-current-liabilities

123.7762.480.6111.6
116.2
119
168
108.2
15.2
27.4
46.6
43.2
43
68
54
46.5

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

1457.93645.3737.1533.1
546.6
500.7
572.5
427.4
332.9
337
313
273.8
200.8
167.9
117.2
94.2

balance-sheet.row.preferred-stock

2204.562204.600
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

61.7830.930.930.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9
30.9

balance-sheet.row.retained-earnings

2178.432178.41979.21491.6
936.6
868.2
667.4
532.1
389.2
275.2
191.9
146.6
117.5
107
82.9
55.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

7047.8120.920.920.9
20.9
16.9
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

-2209.32-2209.31.21.2
1.2
5.2
22.1
22.1
22.1
22.1
22.7
22.7
22.7
22.7
22.7
22.7

balance-sheet.row.total-stockholders-equity

9283.262225.52032.21544.6
989.6
921.2
720.4
585.1
442.1
328.2
245.4
200.2
171.1
160.6
136.5
109.3

balance-sheet.row.total-liabilities-and-stockholders-equity

10741.192870.82769.32077.7
1536.2
1421.9
1292.9
1012.5
775.1
665.2
558.5
474
371.9
328.5
253.6
203.6

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

9283.262225.52032.21544.6
989.6
921.2
720.4
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

10741.19---
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

2494.2387.525.746.3
134.1
80
112.9
50.4
31.1
20.7
4.1
0.4
15.2
16.3
9.8
4.7

balance-sheet.row.total-debt

576.89304.8300164.5
282.3
271.6
266.7
203.9
127.5
131.9
148.2
119
87.5
63.1
50.5
41.4

balance-sheet.row.net-debt

1657.23226.5293.6143.5
278.3
263.7
251.8
183.9
106.4
113.3
140.9
103.7
80
55
40.1
30.5

现金流量表

在 NGL Fine-Chem Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -5.196 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-270204000.000. 与上一年相比， 0.902 发生了变化. 在同一时期，公司记录了 112.91, 32.91 和 -36.15，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-10.81 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 36.15，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln

USD
Growth
TTM202220212020201920182017201620152014201320122011201020092008

cash-flows.row.net-income

380.04273.6666775.9
120.7
275.7
178
220.4
178.7
128.6
67.1
44.4
15.6
24.2
27
16.8

cash-flows.row.depreciation-and-amortization

113.71112.9103.783.3
81.1
63
45.6
30.8
27.2
26
23.2
19.3
13.5
9.3
7.8
7.6

cash-flows.row.deferred-income-tax

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

032.6-474-340.9
-0.3
-191.5
42.9
-71.8
-55.8
-36.9
-70.6
-47.5
-8.8
6.8
-20.2
-27.4

cash-flows.row.account-receivables

0-18.9-264.2-113.6
69.3
-54.6
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0290.1-181.6-99.5
-92.9
-18
-50
-17.9
21
-36.3
13.8
-41
-9.9
-6.5
-3.5
-11.3

cash-flows.row.account-payables

0-125.776.287
47.2
-74.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0-112.9-104.5-214.8
-23.9
-44.7
92.9
-53.9
-76.8
-0.7
-84.4
-6.5
1.1
13.3
-16.7
-16.1

cash-flows.row.other-non-cash-items

-380.04-66.3-157.4-244.8
3.1
-58.7
-42.9
-81.2
-66
-42.6
-22.7
-16.5
-6.4
-1.5
-0.9
-0.5

cash-flows.row.net-cash-provided-by-operating-activities

227.42000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-314.1-563.8-172.1
-149.2
-145
-238.6
-180.5
-99.6
-27.5
-36.4
-46.1
-47.3
-50.1
-22.2
-7

cash-flows.row.acquisitions-net

011272.91.4
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

000-1.4
-22.4
0
0
0
0
0
0
0
0
-6.5
-5
-4.6

cash-flows.row.sales-maturities-of-investments

00061
0
5
4.7
0
0
0
0
15.4
0
0
0
0

cash-flows.row.other-investing-activites

032.9148.8-134.6
-37
44.6
23
3.2
1.7
1.6
0.8
0.8
2.3
1.4
5.5
0.5

cash-flows.row.net-cash-used-for-investing-activites

0-270.2-142-245.7
-208.5
-95.4
-210.9
-177.3
-97.9
-25.9
-35.5
-29.9
-44.9
-55.2
-21.7
-11

cash-flows.row.debt-repayment

0-36.1-159-119.6
-3.9
-3.1
0
-15.1
-12.6
-36.6
0
-6.2
0
0
0
0

cash-flows.row.common-stock-issued

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-10.8-10.8-10.8
-10.8
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

036.1159119.6
1.7
0
0
93
28.9
-1.2
30.5
44
30.4
14
7.6
16.7

cash-flows.row.net-cash-used-provided-by-financing-activities

0-10.8-10.8-10.8
-13
-3.1
0
77.9
16.3
-37.8
30.5
37.9
30.4
14
7.6
16.7

cash-flows.row.effect-of-forex-changes-on-cash

0000
13
3.1
0
0
0
0
0
0
0
0
0
0

cash-flows.row.net-change-in-cash

227.4271.8-14.617
-3.9
-7
12.8
-1.1
2.5
11.4
-8
7.8
-0.5
-2.4
-0.5
2.2

cash-flows.row.cash-at-end-of-period

287.5778.36.421
4
7.9
14.9
20
21.2
18.6
7.3
15.3
7.5
8.1
10.4
10.9

cash-flows.row.cash-at-beginning-of-period

60.156.4214
7.9
14.9
2.1
21.2
18.6
7.3
15.3
7.5
8.1
10.4
10.9
8.6

cash-flows.row.operating-cash-flow

227.42352.9138.2273.5
204.6
88.5
223.6
98.3
84.1
75
-3
-0.2
14
38.8
13.7
-3.5

cash-flows.row.capital-expenditure

0-314.1-563.8-172.1
-149.2
-145
-238.6
-180.5
-99.6
-27.5
-36.4
-46.1
-47.3
-50.1
-22.2
-7

cash-flows.row.free-cash-flow

227.4238.8-425.5101.4
55.5
-56.5
-15
-82.2
-15.5
47.6
-39.4
-46.4
-33.3
-11.2
-8.5
-10.4

利润表行

NGL Fine-Chem Limited 的收入与上期相比变化了 0.227%。据报告, NGLFINE.NS 的毛利润为 1377.6。该公司的营业费用为 1147.31，与上年相比变化了 6.224%. 折旧和摊销费用为 112.91，与上一会计期间相比变化了 0.089%. 营业费用报告为 1147.31，显示6.224% 的同比变化。 销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。 基于近期数据的EBITDA为 0，同比增长-0.136%. 营业收入为 230.29，与上年相比变化了-0.599%. 净利润的变化率为 -0.589%。去年的净收入为204.96.

common:word.in-mln

USD
Growth
TTM2022202120202019201820172016201520142013201220112010200920082007

income-statement-row.row.total-revenue

3169.942780.83128.32550
1489.5
1507.8
1109.4
1001.5
962.9
883.3
788.7
555.7
361.1
350.4
278.2
246.3
126.4

income-statement-row.row.cost-of-revenue

1604.521403.21469.91023.4
643.7
626.4
458.7
380.8
408.2
416.4
403.6
287.3
187.1
301.8
231.9
115.4
56

income-statement-row.row.gross-profit

1565.421377.61658.41526.6
845.9
881.4
650.7
620.7
554.8
466.9
385.1
268.4
174
48.6
46.4
130.9
70.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

53.19---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

153.12---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

6.86---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

92.755.357.212.5
0.8
7.8
7.3
3.5
0.3
277.8
0
1.1
0
5.9
5.2
95.2
64.9

income-statement-row.row.operating-expenses

1145.441147.31080.1763.3
707
586.4
480.7
395.4
366.3
343.3
298.8
213.9
150.5
5.9
5.2
95.2
64.9

income-statement-row.row.cost-and-expenses

2749.972550.525501786.8
1350.6
1212.8
939.4
776.3
774.5
759.7
702.4
501.2
337.6
307.7
237.1
210.6
120.9

income-statement-row.row.interest-income

14.313.21.82
2.2
1.5
1.8
1.5
1.3
1
0.7
0.7
0.5
0.7
0.6
0
0

income-statement-row.row.interest-expense

12.031215.618.4
22.6
22.9
15.5
7.2
11.7
12.5
12.9
11.8
9.2
5.6
2.8
4.3
3.4

income-statement-row.row.selling-and-marketing-expenses

6.86---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

57.9943.391.216.3
-14.5
-19.3
8.1
-4.8
-9.7
5
-19.2
-10.1
-7.9
-4.2
-1.8
-4.3
-3.4

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

92.755.357.212.5
0.8
7.8
7.3
3.5
0.3
277.8
0
1.1
0
5.9
5.2
95.2
64.9

income-statement-row.row.total-operating-expenses

57.9943.391.216.3
-14.5
-19.3
8.1
-4.8
-9.7
5
-19.2
-10.1
-7.9
-4.2
-1.8
-4.3
-3.4

income-statement-row.row.interest-expense

12.031215.618.4
22.6
22.9
15.5
7.2
11.7
12.5
12.9
11.8
9.2
5.6
2.8
4.3
3.4

income-statement-row.row.depreciation-and-amortization

117.22112.9103.783.3
81.1
63
45.6
30.8
27.2
26
23.2
19.3
13.5
9.3
7.8
7.6
5.9

income-statement-row.row.ebitda-caps

593.09---
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

442.66230.3574.8759.6
135.2
295
170
225.3
188.4
123.6
86.3
54.5
23.5
42.7
41.1
35.7
5.5

income-statement-row.row.income-before-tax

500.65273.6666775.9
120.7
275.7
178
220.4
178.7
128.6
67.1
44.4
15.6
38.5
39.4
31.5
2.1

income-statement-row.row.income-tax-expense

120.6168.7167208.7
37.4
74.4
52.1
78
64.7
45.3
21.8
15.4
5.2
14.3
12.3
11.9
0.4

income-statement-row.row.net-income

380.04205499567.2
83.4
201.3
125.9
142.4
114
83.3
45.3
29.1
10.5
24.2
27
16.8
1.6
类似股票
您可能还对以下内容感兴趣：
MARKSANS.NS
Marksans Pharma Limited.
157.9 INR
NSE
2186.HK
Luye Pharma Group Ltd..
3.04 HKD
HKSE
PTKFY
PT Kalbe Farma Tbk..
17.03 USD
PNK
VIRP.PA
Virbac SA.
334 EUR
EURONEXT
DSKYF
Daiichi Sankyo Company, Limited.
35.03 USD
PNK
ALPMF
Astellas Pharma Inc..
9.521 USD
PNK
BMY
Bristol-Myers Squibb Company.
44.04 USD
NYSE
ORNBV.HE
Orion Oyj.
36.11 EUR
HEL
CHGCF
Chugai Pharmaceutical Co., Ltd..
32.43 USD
PNK
NVS
Novartis AG.
99.07 USD
NYSE

常见问题

什么是 NGL Fine-Chem Limited (NGLFINE.NS) 总资产是多少？

NGL Fine-Chem Limited (NGLFINE.NS) 总资产为 2870788000.000.

什么是企业年收入？

年收入为 1681296000.000.

企业利润率是多少？

公司利润率为 0.494.

什么是公司自由现金流？

自由现金流为 36.811.

什么是企业净利润率？

净利润率为 0.120.

企业总收入是多少？

总收入为 0.140.

什么是 NGL Fine-Chem Limited (NGLFINE.NS) 净利润？{{符号}}净利润（净收入）是多少？

净利润（净收入）为 204963000.000.

公司总债务是多少？

债务总额为 304787000.000.

营业费用是多少？

运营支出为 1147310000.000.

公司现金是多少？

企业现金为 -641081000.000.